Color Doppler ultrasound‐guided transducer compression of post biopsy bleeding of kidney transplants

Brabrand, Knut; Midtvedt, Karsten; Günther, Anne; Marthinsen, Pål Bache; Berstad, A

doi:10.1002/jcu.21983

Cited by 3 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After the removal of duplicates, 5004 unique records were identified, of which 4814 records were excluded after the screening of titles and abstracts. Of the 190 remaining studies, 72 studies (40 082 biopsies) 2,3,9,14,25-92 were included in the systematic review and meta-analysis after full-text review (Figure 1) including 4 single-center randomized controlled trials, 3 multicenter cohort studies (1 mixed retrospective-prospective and 2 retrospective), and 65 single-center cohort studies (10 prospective, 1 mixed retrospective-prospective, 46 retrospective, and 8 unreported). Details of the included studies are presented in Table S1, SDC, http://links.lww.com/TP/C332.…”

Section: Resultsmentioning

confidence: 99%

Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis

Lim

Tan

et al. 2022

Transplantation

View full text Add to dashboard Cite

Background. Kidney biopsy is important to guide the management of allograft dysfunction but has a risk of complications. This review aimed to determine the incidence and risk factors of complications after kidney allograft biopsy. Methods. This is a systematic review and meta-analysis of randomized controlled trials, cohort studies, or case-control studies indexed on PubMed, Embase, Cochrane Central Register of Controlled Trials, World Health Organization International Clinical Trials Registry, and ClinicalTrials.gov, limited to the English language, from January 2000 to December 2020, including adult and pediatric kidney allograft biopsies. Primary outcomes were gross hematuria, bleeding requiring transfusion, and major complications (requiring interventions such as blood transfusion or surgical or radiological interventions). Results. The review included 72 studies (40 082 biopsies). The quality of included studies was suboptimal. Pooled rates of gross hematuria, bleeding requiring transfusion, and major complications were 3.18% [95% confidence interval (95% CI), 2.31-4.19], 0.31% (95% CI, 0.15-0.52) and 0.89% (95% CI, 0.61-1.22), respectively. Gross hematuria rates were lower in high-income compared with middle-income countries (2.59% versus 6.44%, P < 0.01) and biopsies performed by radiology as compared with nephrology departments (1.25% versus 3.71%, P < 0.01). Blood transfusion rates were lower in pediatrics than adults (0.0% versus 0.65%, P < 0.01). Major complications were lower in biopsies performed by specialists as compared with trainees (0.02% versus 3.64%, P < 0.01). Graft loss and mortality were extremely rare. Limitations included missing data, few randomized controlled trials, and possible publication bias. Conclusions. The risk of complications after kidney allograft biopsy was low. Given the low quality of included studies, risk factors for complications should be further examined in future studies.

show abstract

Section: Resultsmentioning

confidence: 99%

Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis

Lim

Tan

et al. 2022

Transplantation

View full text Add to dashboard Cite

show abstract

“…Hemorrhage and arteriovenous fistula are the two most common complications. Immediately after biopsy, color Doppler US or CEUS can identify any significant bleeding along the puncture tract which may be treated by US-guided compression [261]. CEUS may be helpful in diagnosing persistent ongoing bleeding, which may be treated by embolization.…”

Section: Kidney Transplant Biopsymentioning

confidence: 99%

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II

et al. 2015

View full text Add to dashboard Cite

This is the second part of the series on interventional ultrasound guidelines of the Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). It deals with the diagnostic interventional procedure. General points are discussed which are pertinent to all patients, followed by organ-specific imaging that will allow the correct pathway and planning for the interventional procedure. This will allow for the appropriate imaging workup for each individual interventional procedure (Long version).

show abstract

“…Following a renal transplant biopsy, the patient should remain in bed and be monitored for ≥ 4 hours. Immediately after biopsy, color Doppler US or CEUS can identify any significant bleeding along the puncture tract which may be treated by USguided compression [176]. CEUS may be helpful in diagnosing persistent ongoing bleeding, which may be treated by embolization.…”

Section: Kidney Transplant Biopsymentioning

confidence: 99%

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II

et al. 2015

View full text Add to dashboard Cite

show abstract

Color Doppler ultrasound‐guided transducer compression of post biopsy bleeding of kidney transplants

Abstract: CDUS detects bleeding and facilitates direct transducer compression of the needle tract in a substantial portion of biopsy procedures of kidney transplants. Only minor hematomas occurred.

Cited by 3 publications

References 14 publications

Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis

Complications of Percutaneous Kidney Allograft Biopsy: Systematic Review and Meta-analysis

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II

EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II

Contact Info

Product

Resources

About